HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Paranasal Sinus Cancer

Paranasal Sinus Cancer

Paranasal sinus cancer, though rare, presents significant challenges in both diagnosis and treatment. These cancers originate in the nasal cavity and sinuses, often diagnosed at an advanced stage due to their subtle symptoms like congestion or facial pain. Research in this area focuses on improving early detection methods, such as imaging techniques and biomarker identification, to enable timely interventions.

Furthermore, advancements in treatment modalities like surgery, radiation therapy, and chemotherapy aim to enhance outcomes and preserve quality of life for patients. Immunotherapy and targeted therapies also hold promise in addressing specific genetic mutations driving these cancers. Collaborative efforts between oncologists, surgeons, and researchers are vital in unraveling the complexities of paranasal sinus cancer and devising more effective strategies to combat it.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp